Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample

Willa D. Brenowitz, Rebecca A. Hubbard, C. Dirk Keene, Stephen E. Hawes, W. T. Longstreth, Randall (Randy) Woltjer, Walter A. Kukull

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Introduction: Whether co-occurring neuropathologies interact or independently affect clinical disease progression is uncertain. We estimated rates of clinical progression and tested whether associations between clinical progression and Alzheimer's disease neuropathology (ADNP) were modified by co-occurring Lewy body disease (LBD) or vascular brain injury (VBI). Methods: Linear mixed effects models evaluated longitudinal trends in the Clinical Dementia Rating Scale Sum of Boxes on 2046 autopsied participants seen at a U.S. Alzheimer's Disease Center. Results: Annual clinical progression was slightly faster for ADNP + LBD compared with ADNP only (P = .06) and slightly slower for ADNP + VBI (P = .003). Differences in progression were less than expected if each neuropathology independently contributed to progression; ADNP interacted with LBD (P = .002) and VBI (P = .003). In secondary models, the effect of additional pathologies on clinical progression was greater in those with intermediate compared with high levels of ADNP. Discussion: The impact of co-occurring pathologies on progression may depend on severity of ADNP.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
DOIs
StateAccepted/In press - 2016

Fingerprint

Autopsy
Alzheimer Disease
Cerebrovascular Trauma
Lewy Body Disease
Neuropathology
Clinical Pathology
Dementia
Disease Progression
Pathology

Keywords

  • Alzheimer's disease neuropathology
  • Cerebrovascular disease
  • Clinical progression
  • Lewy body disease
  • Mixed neuropathology

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Geriatrics and Gerontology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Brenowitz, W. D., Hubbard, R. A., Keene, C. D., Hawes, S. E., Longstreth, W. T., Woltjer, R. R., & Kukull, W. A. (Accepted/In press). Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimer's and Dementia. https://doi.org/10.1016/j.jalz.2016.09.015

Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. / Brenowitz, Willa D.; Hubbard, Rebecca A.; Keene, C. Dirk; Hawes, Stephen E.; Longstreth, W. T.; Woltjer, Randall (Randy); Kukull, Walter A.

In: Alzheimer's and Dementia, 2016.

Research output: Contribution to journalArticle

Brenowitz, Willa D. ; Hubbard, Rebecca A. ; Keene, C. Dirk ; Hawes, Stephen E. ; Longstreth, W. T. ; Woltjer, Randall (Randy) ; Kukull, Walter A. / Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. In: Alzheimer's and Dementia. 2016.
@article{4a35875518714f128663d90b4c605671,
title = "Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample",
abstract = "Introduction: Whether co-occurring neuropathologies interact or independently affect clinical disease progression is uncertain. We estimated rates of clinical progression and tested whether associations between clinical progression and Alzheimer's disease neuropathology (ADNP) were modified by co-occurring Lewy body disease (LBD) or vascular brain injury (VBI). Methods: Linear mixed effects models evaluated longitudinal trends in the Clinical Dementia Rating Scale Sum of Boxes on 2046 autopsied participants seen at a U.S. Alzheimer's Disease Center. Results: Annual clinical progression was slightly faster for ADNP + LBD compared with ADNP only (P = .06) and slightly slower for ADNP + VBI (P = .003). Differences in progression were less than expected if each neuropathology independently contributed to progression; ADNP interacted with LBD (P = .002) and VBI (P = .003). In secondary models, the effect of additional pathologies on clinical progression was greater in those with intermediate compared with high levels of ADNP. Discussion: The impact of co-occurring pathologies on progression may depend on severity of ADNP.",
keywords = "Alzheimer's disease neuropathology, Cerebrovascular disease, Clinical progression, Lewy body disease, Mixed neuropathology",
author = "Brenowitz, {Willa D.} and Hubbard, {Rebecca A.} and Keene, {C. Dirk} and Hawes, {Stephen E.} and Longstreth, {W. T.} and Woltjer, {Randall (Randy)} and Kukull, {Walter A.}",
year = "2016",
doi = "10.1016/j.jalz.2016.09.015",
language = "English (US)",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample

AU - Brenowitz, Willa D.

AU - Hubbard, Rebecca A.

AU - Keene, C. Dirk

AU - Hawes, Stephen E.

AU - Longstreth, W. T.

AU - Woltjer, Randall (Randy)

AU - Kukull, Walter A.

PY - 2016

Y1 - 2016

N2 - Introduction: Whether co-occurring neuropathologies interact or independently affect clinical disease progression is uncertain. We estimated rates of clinical progression and tested whether associations between clinical progression and Alzheimer's disease neuropathology (ADNP) were modified by co-occurring Lewy body disease (LBD) or vascular brain injury (VBI). Methods: Linear mixed effects models evaluated longitudinal trends in the Clinical Dementia Rating Scale Sum of Boxes on 2046 autopsied participants seen at a U.S. Alzheimer's Disease Center. Results: Annual clinical progression was slightly faster for ADNP + LBD compared with ADNP only (P = .06) and slightly slower for ADNP + VBI (P = .003). Differences in progression were less than expected if each neuropathology independently contributed to progression; ADNP interacted with LBD (P = .002) and VBI (P = .003). In secondary models, the effect of additional pathologies on clinical progression was greater in those with intermediate compared with high levels of ADNP. Discussion: The impact of co-occurring pathologies on progression may depend on severity of ADNP.

AB - Introduction: Whether co-occurring neuropathologies interact or independently affect clinical disease progression is uncertain. We estimated rates of clinical progression and tested whether associations between clinical progression and Alzheimer's disease neuropathology (ADNP) were modified by co-occurring Lewy body disease (LBD) or vascular brain injury (VBI). Methods: Linear mixed effects models evaluated longitudinal trends in the Clinical Dementia Rating Scale Sum of Boxes on 2046 autopsied participants seen at a U.S. Alzheimer's Disease Center. Results: Annual clinical progression was slightly faster for ADNP + LBD compared with ADNP only (P = .06) and slightly slower for ADNP + VBI (P = .003). Differences in progression were less than expected if each neuropathology independently contributed to progression; ADNP interacted with LBD (P = .002) and VBI (P = .003). In secondary models, the effect of additional pathologies on clinical progression was greater in those with intermediate compared with high levels of ADNP. Discussion: The impact of co-occurring pathologies on progression may depend on severity of ADNP.

KW - Alzheimer's disease neuropathology

KW - Cerebrovascular disease

KW - Clinical progression

KW - Lewy body disease

KW - Mixed neuropathology

UR - http://www.scopus.com/inward/record.url?scp=85008599124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008599124&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2016.09.015

DO - 10.1016/j.jalz.2016.09.015

M3 - Article

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

ER -